Improving Mothers for a Better PrenAtal Care Trial Barcelona (IMPACTBCN)
Primary Purpose
Intrauterine Growth Restriction, Fetal Growth Retardation
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Mediterranean diet
Mindfulness
Sponsored by
About this trial
This is an interventional prevention trial for Intrauterine Growth Restriction focused on measuring Mindfulness, Mediterranean diet, Neurodevelopment, Epigenetics, Fetal growth restriction
Eligibility Criteria
Inclusion Criteria:
- Maternal age at recruitment ≥18 years
- Speak Spanish fluently
- Viable singleton non-malformed fetus
- High-risk pregnancy to develop FGR.
- 19-23 weeks of gestation
Exclusion Criteria:
- Fetal anomalies including chromosomal abnormalities or structural malformations detected by ultrasound.
- Mental retardation or other mental or psychiatric disorders that impose doubts regarding the true patient´s willingness to participate in the study.
- No possibility to come to additional visits.
Sites / Locations
- Hospital Clinic Barcelona
- Hospital Sant Joan de Deu
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
No Intervention
Arm Label
Mediterranean diet
Mindfulness
No intervention
Arm Description
Mediterranean diet supplemented with extra-virgin olive oil and mixed nuts.
Mindfulness-Based Stress Reduction program (MBSR)
No intervention strategy
Outcomes
Primary Outcome Measures
Fetal Growth Restriction (FGR)
Birth weight <10th percentile
Secondary Outcome Measures
Adverse Perinatal Outcome (APO) Adverse Perinatal Outcome (APO)
Development of one of the following conditions: preeclampsia, preterm delivery, severe FGR (birth weight <3rd percentile), perinatal mortality, metabolic acidosis, mejor neonatal morbidity (presence of intraventricular hemorrhage grade III/IV, necrotizing enterocolitis, periventricular leucomalacia, sepsis, broncopulmonary dysplasia, hypoxic ischemic encephalopathy)
Full Information
NCT ID
NCT03166332
First Posted
April 19, 2017
Last Updated
April 16, 2022
Sponsor
Hospital Clinic of Barcelona
1. Study Identification
Unique Protocol Identification Number
NCT03166332
Brief Title
Improving Mothers for a Better PrenAtal Care Trial Barcelona
Acronym
IMPACTBCN
Official Title
Improving Mothers for a Better PrenAtal Care Trial Barcelona
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
February 1, 2017 (Actual)
Primary Completion Date
December 31, 2020 (Actual)
Study Completion Date
December 31, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Clinic of Barcelona
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
High risk women for growth restricted fetuses will randomized in the second trimester into different strategies applied to the mothers: a stress reduction program based on mindfulness techniques or a nutrition interventional program based on Mediterranean diet.
Detailed Description
Randomized controlled trial among women at higher risk to have a growth restricted fetus (30%) according to Royal College of Obstetrics and Gynecology (RCOG) Guidelines. These high-risk women will be randomized in order to evaluate an improvement in several outcomes thanks to different strategies applied to the mothers: a stress reduction program based on mindfulness techniques or a nutrition interventional program based on Mediterranean diet.
Main hypothesis: specific interventions improving maternal lifestyle and well being have a positive impact on pregnancy outcomes as well as on fetal growth and development.
Secondary hypothesis is that interventions to improve maternal lifestyle well being have a positive impact on offspring's outcome later in life, in terms of neurodevelopment and cardiovascular profile, mediated by epigenetic changes in offspring.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intrauterine Growth Restriction, Fetal Growth Retardation
Keywords
Mindfulness, Mediterranean diet, Neurodevelopment, Epigenetics, Fetal growth restriction
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial with 3 arms of intervention
Masking
Care Provider
Masking Description
Care provider will not know the arm of randomization
Allocation
Randomized
Enrollment
1221 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Mediterranean diet
Arm Type
Active Comparator
Arm Description
Mediterranean diet supplemented with extra-virgin olive oil and mixed nuts.
Arm Title
Mindfulness
Arm Type
Active Comparator
Arm Description
Mindfulness-Based Stress Reduction program (MBSR)
Arm Title
No intervention
Arm Type
No Intervention
Arm Description
No intervention strategy
Intervention Type
Behavioral
Intervention Name(s)
Mediterranean diet
Intervention Description
Mediterranean diet supplemented with extra-virgin olive oil and nuts
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness
Intervention Description
Mindfulness-Based Stress Reduction program (MBSR)
Primary Outcome Measure Information:
Title
Fetal Growth Restriction (FGR)
Description
Birth weight <10th percentile
Time Frame
Delivery
Secondary Outcome Measure Information:
Title
Adverse Perinatal Outcome (APO) Adverse Perinatal Outcome (APO)
Description
Development of one of the following conditions: preeclampsia, preterm delivery, severe FGR (birth weight <3rd percentile), perinatal mortality, metabolic acidosis, mejor neonatal morbidity (presence of intraventricular hemorrhage grade III/IV, necrotizing enterocolitis, periventricular leucomalacia, sepsis, broncopulmonary dysplasia, hypoxic ischemic encephalopathy)
Time Frame
Pregnancy
Other Pre-specified Outcome Measures:
Title
Fetal Programming
Description
Neurodevelopment assessment with Bayley III test
Time Frame
Up to 24 months of age
Title
Epigenetics
Description
Different epigenetic changes in fetal cord blood in pregnancies affected by FGR who attend the interventional program as compared to pregnancies with no intervention
Time Frame
Delivery
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Maternal age at recruitment ≥18 years
Speak Spanish fluently
Viable singleton non-malformed fetus
High-risk pregnancy to develop FGR.
19-23 weeks of gestation
Exclusion Criteria:
Fetal anomalies including chromosomal abnormalities or structural malformations detected by ultrasound.
Mental retardation or other mental or psychiatric disorders that impose doubts regarding the true patient´s willingness to participate in the study.
No possibility to come to additional visits.
Facility Information:
Facility Name
Hospital Clinic Barcelona
City
Barcelona
ZIP/Postal Code
08036
Country
Spain
Facility Name
Hospital Sant Joan de Deu
City
Barcelona
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Participants will be recruited in our unit and data will be available only for researchers involved in the study.
Citations:
PubMed Identifier
34874420
Citation
Crovetto F, Crispi F, Casas R, Martin-Asuero A, Borras R, Vieta E, Estruch R, Gratacos E; IMPACT BCN Trial Investigators. Effects of Mediterranean Diet or Mindfulness-Based Stress Reduction on Prevention of Small-for-Gestational Age Birth Weights in Newborns Born to At-Risk Pregnant Individuals: The IMPACT BCN Randomized Clinical Trial. JAMA. 2021 Dec 7;326(21):2150-2160. doi: 10.1001/jama.2021.20178.
Results Reference
derived
PubMed Identifier
34030703
Citation
Crovetto F, Crispi F, Borras R, Paules C, Casas R, Martin-Asuero A, Arranz A, Vieta E, Estruch R, Gratacos E. Mediterranean diet, Mindfulness-Based Stress Reduction and usual care during pregnancy for reducing fetal growth restriction and adverse perinatal outcomes: IMPACT BCN (Improving Mothers for a better PrenAtal Care Trial BarCeloNa): a study protocol for a randomized controlled trial. Trials. 2021 May 24;22(1):362. doi: 10.1186/s13063-021-05309-2.
Results Reference
derived
Learn more about this trial
Improving Mothers for a Better PrenAtal Care Trial Barcelona
We'll reach out to this number within 24 hrs